Cargando…

Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study

Decreased levels of brain-derived neurotrophic factor (BDNF) are assumed to play a crucial role in the pathophysiology of mild neurocognitive disorders (MNCDs). In this study, we compared plasma BDNF levels (at baseline and after two months of treatment with escitalopram) in patients with the main t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levada, Oleg A., Cherednichenko, Nataliya V., Trailin, Andriy V., Troyan, Alexandra S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997080/ https://www.ncbi.nlm.nih.gov/pubmed/27597800 http://dx.doi.org/10.1155/2016/4095723

Ejemplares similares

Neuropsychiatric Symptoms in Patients with the Main Etiological Types of Mild Neurocognitive Disorders: A Hospital-Based Case–Control Study
por: Levada, Oleg A., et al.
Publicado: (2017)

The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy
por: Troyan, Alexandra S., et al.
Publicado: (2020)

Poststroke Depression Biomarkers: A Narrative Review
por: Levada, Oleg A., et al.
Publicado: (2018)

Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder
por: Levada, Oleg A., et al.
Publicado: (2017)

Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine study
por: Levada, Oleg A., et al.
Publicado: (2020)

High Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study
por: Trailin, Andriy V., et al.
Publicado: (2015)

High urinary interleukin-2 in late post-transplant period portends a risk of decline in kidney allograft function: a preliminary study
por: Trailin, Andriy V., et al.
Publicado: (2017)

Comparison of Neurocognitive Testing and the Measurement of Marinobufagenin in Mild Traumatic Brain Injury: A Preliminary Report
por: Oliver, Joel, et al.
Publicado: (2015)

Missense Mutation of Brain Derived Neurotrophic Factor (BDNF) Alters Neurocognitive Performance in Patients with Mild Traumatic Brain Injury: A Longitudinal Study
por: Narayanan, Vairavan, et al.
Publicado: (2016)

Brain-derived neurotrophic factor in main neurodegenerative diseases
por: Camuso, Serena, et al.
Publicado: (2022)

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS)
por: Li, Danni, et al.
Publicado: (2016)

Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer
por: Wróbel-Dudzińska, Dominika, et al.
Publicado: (2018)

Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study
por: Ng, Ted Kheng Siang, et al.
Publicado: (2021)

Efficacy of Plasma Rich in Growth Factors (PRGF) in Stage 1 Neurotrophic Keratitis
por: Ghalibafan, Seyyedehfatemeh, et al.
Publicado: (2023)

Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease
por: Ou, Zhen-Yi Andy, et al.
Publicado: (2021)

Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease
por: Lucza, Tivadar, et al.
Publicado: (2015)

Transcranial pulse stimulation in the treatment of mild neurocognitive disorders
por: Fong, Tommy Kwan Hin, et al.
Publicado: (2023)

Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival
por: Trailin, Andriy V., et al.
Publicado: (2017)

Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study
por: Li, Danni, et al.
Publicado: (2016)

The Role of Brain Derived Neurotrophic Factor in HIV-Associated Neurocognitive Disorder: From the Bench-Top to the Bedside
por: Michael, Henry, et al.
Publicado: (2020)

Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies
por: Ali, Esraa, et al.
Publicado: (2022)

Long Non-Coding RNA and microRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment
por: Rajtmajerová, Marie, et al.
Publicado: (2022)

Brain-derived neurotrophic factor as biomarker
por: Sookaromdee, Pathum, et al.
Publicado: (2020)

Mild Neurocognitive Disorder: An Old Wine in a New Bottle
por: Stokin, Gorazd B., et al.
Publicado: (2015)

Heavy metal deposition through precipitation in Kazakhstan
por: Cherednichenko, V.S., et al.
Publicado: (2021)

Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study
por: Yoshimura, Reiji, et al.
Publicado: (2018)

Improvement in neurocognitive functions and serum brain-derived neurotrophic factor levels in patients with depression treated with antidepressants and yoga
por: Halappa, Naveen Gowrapura, et al.
Publicado: (2018)

Selective vulnerabilities and biomarkers in neurocognitive aging
por: Reagh, Zachariah, et al.
Publicado: (2017)

Neurocognitive Findings in Compulsive Sexual Behavior: A Preliminary Study
por: Derbyshire, Katherine L., et al.
Publicado: (2015)

Rodent Models of Depression: Neurotrophic and Neuroinflammatory Biomarkers
por: Stepanichev, Mikhail, et al.
Publicado: (2014)

Inflectional zero morphology – Linguistic myth or neurocognitive reality?
por: Alekseeva, Maria, et al.
Publicado: (2022)

Group Intensive Cognitive Activation in Patients with Major or Mild Neurocognitive Disorder
por: Panerai, Simonetta, et al.
Publicado: (2016)

Computerized Neurocognitive Test (CNT) in mild cognitive impairment and Alzheimer's disease
por: de Oliveira, Maira Okada, et al.
Publicado: (2014)

Neurocognitive and Behavioral Indexes for Identifying the Amnestic Subtypes of Mild Cognitive Impairment
por: Cid-Fernández, Susana, et al.
Publicado: (2017)

Clinical validation of an optimized multimodal neurocognitive assessment of chronic mild TBI
por: Ettenhofer, Mark L., et al.
Publicado: (2020)

Neurocognition of Aged Patients With Chronic Tinnitus: Focus on Mild Cognitive Impairment
por: Lee, Sang-Yeon, et al.
Publicado: (2020)

Frequent neurocognitive deficits after recovery from mild COVID-19
por: Woo, Marcel S, et al.
Publicado: (2020)

Gender-specific Associations of the Brain-derived Neurotrophic Factor Val66Met Polymorphism with Neurocognitive and Clinical Features in Schizophrenia
por: Kim, Sung-Wan, et al.
Publicado: (2016)

Plasma Brain-derived Neurotrophic Factor in Hemodialysis Patients
por: Shin, Seok Joon, et al.
Publicado: (2012)

Plasma microRNA biomarkers for detection of mild cognitive impairment
por: Sheinerman, Kira S., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g6vt37h5qlvjflso5ovtfe9k7u